Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial

Fig. 1

Cognitive functioning at baseline, after 1 year of GH treatment and after 1 year of placebo. Total, performance and verbal IQ at baseline (in light grey), after 1 year of placebo (in white) and after 1 year of GH treatment (in dark grey). Boxes represent 1st and 3rd quartile, with median in the middle. Whiskers indicate range. There are no significant differences

Back to article page